GB202003057D0 - Medicament and use thereof - Google Patents

Medicament and use thereof

Info

Publication number
GB202003057D0
GB202003057D0 GBGB2003057.3A GB202003057A GB202003057D0 GB 202003057 D0 GB202003057 D0 GB 202003057D0 GB 202003057 A GB202003057 A GB 202003057A GB 202003057 D0 GB202003057 D0 GB 202003057D0
Authority
GB
United Kingdom
Prior art keywords
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2003057.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aimsco Ltd
Original Assignee
Aimsco Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aimsco Ltd filed Critical Aimsco Ltd
Priority to GBGB2003057.3A priority Critical patent/GB202003057D0/en
Publication of GB202003057D0 publication Critical patent/GB202003057D0/en
Ceased legal-status Critical Current

Links

GBGB2003057.3A 2020-03-03 2020-03-03 Medicament and use thereof Ceased GB202003057D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB2003057.3A GB202003057D0 (en) 2020-03-03 2020-03-03 Medicament and use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2003057.3A GB202003057D0 (en) 2020-03-03 2020-03-03 Medicament and use thereof

Publications (1)

Publication Number Publication Date
GB202003057D0 true GB202003057D0 (en) 2020-04-15

Family

ID=70278560

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2003057.3A Ceased GB202003057D0 (en) 2020-03-03 2020-03-03 Medicament and use thereof

Country Status (1)

Country Link
GB (1) GB202003057D0 (en)

Similar Documents

Publication Publication Date Title
IL284835A (en) Pharmaceutical combination comprising tno155 and ribociclib
EP3854816A4 (en) Anti-b7h3 antibody-exatecan analog conjugate and medicinal use thereof
IL285148A (en) Bi-ligand drug conjugate and use thereof
ZA202107920B (en) Fluorine-containing compound and anti-cancer medical use thereof
EP4183391A4 (en) Pharmaceutical composition and use thereof
IL311331A (en) Pharmaceutical composition and use thereof
EP4079738A4 (en) Anticancer compound and medical use thereof
EP3999056A4 (en) Pharmaceutical combination and use thereof
EP4140480A4 (en) Drug combination and use thereof
EP4129283A4 (en) Pharmaceutical combination and use thereof
GB2600270B (en) Polymer-comrprising medical devices and uses thereof
EP4069233A4 (en) Pharmaceutical combination and use thereof
GB2590793B (en) Cannabidiol-C1 for use as a medicament and in the treatment of epilepsy
GB202019475D0 (en) Therapeutic compounds and their use
GB202104690D0 (en) Terpenophenolic compounds and their use
GB202104122D0 (en) Compounds and their use
GB202003057D0 (en) Medicament and use thereof
IL282142A (en) 4-pyrazin-2-ylmethyl-morpholine derivatives and the use thereof as medicament
GB201918541D0 (en) Therapeutic compounds and their use
EP4129282A4 (en) Pharmaceutical combination and use thereof
IL292646A (en) Pharmaceutical combination and use thereof
EP4090159A4 (en) Pyrazolylpyrimidines and use thereof
GB201902087D0 (en) Medicament and the use thereof
GB201802743D0 (en) Medicament and use thereof
GB202108572D0 (en) Therapeutic compounds and their use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)